NEVRO CORP. Convertible Securities: Converted or Retired
Securities that convert into the company's stock: convertible notes (from each offering's SEC filings, as on Outstanding Bonds) and convertible preferred stock (from its final term sheet or the 10-K, as on Preferred Shares), newest issue first. Values are as filed.
- 2.75% Convertible Senior Notes due 2025: Type Convertible notes; Issued 2020-04-06; Amount issued $165,000,000; Conversion terms Approximately $105.00 per share of our common stock. 9.5238 shares of our common stock per $1,000 principal amount of Notes..
- 1.75% Convertible Senior Notes due 2021: Type Convertible notes; Issued 2016-06-13; Amount issued $150,000,000; Conversion terms Approximately $96.37 per share of our common stock. 10.3770 shares of our common stock per $1,000 principal amount of Notes..
| Security | Type | Issued | Amount issued | Conversion terms | Maturity | Converted or retired | Outstanding | Source |
|---|---|---|---|---|---|---|---|---|
| 2.75% Convertible Senior Notes due 2025 | Convertible notes | 2020-04-06 | $165,000,000 | Approximately $105.00 per share of our common stock. 9.5238 shares of our common stock per $1,000 principal amount of Notes. | 2025-04-01 | Repaid at maturity 2025-04-01: $165,000,000 | $0 | 2020-04-03 |
| 1.75% Convertible Senior Notes due 2021 | Convertible notes | 2016-06-13 | $150,000,000 | Approximately $96.37 per share of our common stock. 10.3770 shares of our common stock per $1,000 principal amount of Notes. | 2021-06-01 | Repaid at maturity 2021-06-01: $150,000,000 | $0 | 2016-06-08 |